3685 related articles for article (PubMed ID: 32697968)
1. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
2. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
[TBL] [Abstract][Full Text] [Related]
3. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
[TBL] [Abstract][Full Text] [Related]
4. Spike mutation D614G alters SARS-CoV-2 fitness.
Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671
[TBL] [Abstract][Full Text] [Related]
5. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.
Ahmadpour D; Ahmadpoor P; Rostaing L
Iran J Kidney Dis; 2020 Sep; 14(5):331-334. PubMed ID: 32943587
[TBL] [Abstract][Full Text] [Related]
6. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
7. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
Long SW; Olsen RJ; Christensen PA; Bernard DW; Davis JJ; Shukla M; Nguyen M; Saavedra MO; Yerramilli P; Pruitt L; Subedi S; Kuo HC; Hendrickson H; Eskandari G; Nguyen HAT; Long JH; Kumaraswami M; Goike J; Boutz D; Gollihar J; McLellan JS; Chou CW; Javanmardi K; Finkelstein IJ; Musser JM
mBio; 2020 Oct; 11(6):. PubMed ID: 33127862
[TBL] [Abstract][Full Text] [Related]
8. Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic.
Martin J; Klapsa D; Wilton T; Zambon M; Bentley E; Bujaki E; Fritzsche M; Mate R; Majumdar M
Viruses; 2020 Oct; 12(10):. PubMed ID: 33050264
[TBL] [Abstract][Full Text] [Related]
9. Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020.
Leung K; Pei Y; Leung GM; Lam TT; Wu JT
Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886945
[TBL] [Abstract][Full Text] [Related]
10. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
[TBL] [Abstract][Full Text] [Related]
11. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
Omotuyi IO; Nash O; Ajiboye OB; Iwegbulam CG; Oyinloye EB; Oyedeji OA; Kashim ZA; Okaiyeto K
J Comput Chem; 2020 Sep; 41(24):2158-2161. PubMed ID: 32779780
[TBL] [Abstract][Full Text] [Related]
12. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
Isabel S; Graña-Miraglia L; Gutierrez JM; Bundalovic-Torma C; Groves HE; Isabel MR; Eshaghi A; Patel SN; Gubbay JB; Poutanen T; Guttman DS; Poutanen SM
Sci Rep; 2020 Aug; 10(1):14031. PubMed ID: 32820179
[TBL] [Abstract][Full Text] [Related]
14. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
15. Mutations Strengthened SARS-CoV-2 Infectivity.
Chen J; Wang R; Wang M; Wei GW
J Mol Biol; 2020 Sep; 432(19):5212-5226. PubMed ID: 32710986
[TBL] [Abstract][Full Text] [Related]
16. How does SARS-CoV-2 cause COVID-19?
Matheson NJ; Lehner PJ
Science; 2020 Jul; 369(6503):510-511. PubMed ID: 32732413
[No Abstract] [Full Text] [Related]
17. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
18. A SARS-CoV-2 variant with the 12-bp deletion at E gene.
Sun YS; Xu F; An Q; Chen C; Yang ZN; Lu HJ; Chen JC; Yao PP; Jiang JM; Zhu HP
Emerg Microbes Infect; 2020 Dec; 9(1):2361-2367. PubMed ID: 33118859
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
Tan HW; Xu YM; Lau ATY
Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate.
Becerra-Flores M; Cardozo T
Int J Clin Pract; 2020 Aug; 74(8):e13525. PubMed ID: 32374903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
